The current prices are delayed, login to your account for live prices
Login

Logo

EMCURE PHARMACEUTICALS L Share Price

EMCURE
₹ 1,736.20
+₹52.90 (3.14%)
1D
Last updated 12 Jun, 2026, 15:44 IST
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target

₹1,679.00
3.14% up today
₹1,747.00
1D LOW
1D HIGH
Open
₹1,692.50
High
₹1,747.00
Low
₹1,679.00
Prev. close
₹1,683.30

Circuit
L
H
₹1,562.60
₹1,909.80
52-week
L
H
₹1,228.90
₹1,830.00

EMCURE PHARMACEUTICALS L Shareholder Returns

EMCURE PHARMACEUTICALS L Share Price History

Mkt Cap Cr
32,891.70

P/E
34.94

P/B
6.64

ROE
18.67%

D/E
0.43
ROCE
21.76%

Div. Yield

EPS(TTM)
38.67

Turnover

EV/EBITDA
18.60
Net Margin
0.00%

Op. Margin
0.00%

ROA
9.79%

Quick Ratio
0.00

Curr. Ratio
1.98
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Emcure Pharma outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Emcure Pharma appears to be fairly valued compared to its peers
Step 5 of 5
Earnings
Excellent
Emcure Pharma revenue, operating profit and net profit are growing

EMCURE PHARMACEUTICALS L Financials

Full statement

Consolidated - Yearly
All values are in INR Crore
Consolidated
Annually
* All values are in INR Crore
Qty
Bid
106
1736.2
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 106
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
Indicator
Value
Verdict

RSI (14)
54.56
Neutral

ATR (14)
62
Neutral

STOCH(9,6)
45.83
Neutral

STOCH RSI (14)
57.46
Neutral

ADX(9)
29.68
Bearish

UO(9)
36.87
Neutral

ROC(12)
2.22
Bullish

WillR(14)
-54.17
Neutral
Period
Simple value
Exponential vaue

5D
1722.98
1722.8

10D
1722.72
1721.7

20D
1719.29
1712.06

50D
1668.43
1665.59

100D
1581.7
1597.27
About EMCURE PHARMACEUTICALS L
EMCURE PHARMACEUTICALS L logo
NSE Symbol
EMCURE
BSE Symbol
BSE: 544210
ISIN
INE168P01015
Sector Market Cap
₹ 32,891.7 Cr

Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and APIs. It operates across a wide scope of areas, including gynecological, cardiology, antivirals, vitamins, pain/analgesics, anti-neoplastic, diabetes, anti-infective, respiratory, CNS and nephrology. Its brands include OROFER (Gynecological), BEVON (Vitamins), ZOSTUM (Anti- infectives), Ferium (Gynecological), EXHEP (Cardiovascular), Maxtra (Respiratory) and Pause (Blood-Related). Its API products include S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (cardiology), Vintor (nephrology), Xgrast (anti-neoplastic) and Pegex (anti- neoplastic). It has developed two platforms: Mammalian and Microbial.As of 15 Jun 2026, EMCURE PHARMACEUTICALS L share price is ₹1,736.20. The stock opened at ₹1,692.50, compared to its previous close of ₹1,683.30. During today's trading session, EMCURE PHARMACEUTICALS L share price moved in the range of ₹1,679.00 to ₹1,747.00, with an average price of ₹1,713.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,679.00 and a high of ₹1,747.00. On the performance front, EMCURE PHARMACEUTICALS L share price has increased by 20.69% over the last six months and is up 26.19% on a year-on-year basis.

The market capitalization of EMCURE PHARMACEUTICALS L is ₹32,892 Crs, with a P/E ratio of 34.9 and a dividend yield of 0.21%.

FAQs on EMCURE PHARMACEUTICALS L